Intellia Therapeutics to Present at November Investor Healthcare Conferences
Oct 31, 2016 11:00 am UTC| Business
CAMBRIDGE, Mass., Oct. 31, 2016 -- Intellia Therapeutics, Inc. (NASDAQ:NTLA),a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR/Cas9 technology, announced that...
Oct 31, 2016 11:00 am UTC| Business
SANTA MONICA, Calif., Oct. 31, 2016 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders,...
Xunlei Limited Schedules 2016 Unaudited Third Quarter Earnings Release on November 9, 2016
Oct 31, 2016 10:55 am UTC| Business
SHENZHEN, China, Oct. 31, 2016 -- Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq:XNET), a leading cloud-based acceleration technology company in China, announced today that it plans to release its unaudited...
CONE Midstream Anticipates Continued Growth Following Separation of Sponsors’ Upstream JV
Oct 31, 2016 10:49 am UTC| Business
CANONSBURG, Pa., Oct. 31, 2016 -- CONSOL Energy Inc. (NYSE:CNX) (“CONSOL”) and Noble Energy, Inc. (NYSE:NBL) (“Noble”), whom we refer to as our Sponsors, today jointly announced that the two companies have entered into...
Ingram Micro Expands Use of Descartes’ Denied Party Screening Solution to Europe
Oct 31, 2016 10:45 am UTC| Business
WATERLOO, Ontario, Oct. 31, 2016 -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Ingram Micro Inc. (NYSE:IM), a leader and...
Bernhard Hampl Appointed to the Board of Directors of Cambrex Corporation
Oct 31, 2016 10:45 am UTC| Business
EAST RUTHERFORD, N.J., Oct. 31, 2016 -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Bernhard Hampl was...
Oct 31, 2016 10:30 am UTC| Business
CAMBRIDGE, Mass., Oct. 31, 2016 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that it has entered into two Cooperative Research and...
U.S. payrolls exceeded expectations significantly, while the unemployment rate dropps to 4.1%.